bibliographic resource 3052585 [br/3052585]
https://w3id.org/oc/corpus/br/3052585

is a
title
  • Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
publication date
  • 2010-01-01
contributor
format
identifier
part of